Mild Stroke Study 3 completed participant recruitment
Mild Stroke Study 3 completed participant recruitment. The last participant was recruited in December 2021.
The study reached a total of 230 participants. Over the next year, the Mild Stroke Study 3 research team will continue follow up visits aiming to assess medical and cognitive aspects of stroke, including data collected through numerous questionnaires and medical imaging of brain and retinal vasculature.
About Mild Stroke Study 3
Mild Stroke Study 3 (MSS3), led by Professor Joanna Wardlaw aims is to improve understanding of what makes small vessel disease (SVD) worsen. The study also aims to identify novel ways for SVD prevention and treatment.
Mild Stroke Study 3 Team
Mild Stroke Study 3 research team consisting of scientists coming from multidisciplinary backgrounds, working together to deliver best outcomes in understanding the mechanisms and repercussions of stroke. The team working on the Mild Stroke Study 3 comprises of highly trained clinicians, research nurses, retinal and MRI imaging specialists, psychologists, medical physicists, engineers and statisticians, as well as PhD and international students and research support, working together in a team.
International visiting students
Recognitions and Awards
To date, the study team has successfully published several research papers. Mild Stroke Study 3 was presented at key international conferences and has received numerous recognisions.